Position in SVRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$378,950
+$52,284 QoQ
Shares Held
61,518
+2.8% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 181 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. SVRA ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in SVRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $378,950 | 61,518 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $326,666 | 59,829 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $335,985 | 55,719 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $157,883 | 44,225 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $127,681 | 56,001 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $260,072 | 93,889 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $48,701 | 15,864 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||